Schedule 13G ownership disclosure

NOVOCURE LTD ORD SHS

Security class unavailable · CUSIP: G6674U108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,547,336
Percent of class
9.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-016595
Form type
SC 13G/A
Filer
NovoCure Ltd
CIK
CIK 1645113
Filed
Feb 09, 2023
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub